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Abstract: Current research efforts to improve immunoassay–biosensor functionality have 
centered on detection through the optimal design of microﬂ  uidic chambers, electrical circuitry, 
optical sensing elements, and so on. To date, little attention has been paid to the immunoas-
say–biosensor membrane surface on which interactions between antibodies and antigens must 
occur. For this reason, the objective of the present study was to manipulate the nanometer surface 
roughness of a model immunoassay–biosensor membrane to determine its role on sensitivity 
and speciﬁ  city. It was hypothesized that surface roughness characteristics similar to those used 
by the body’s own immune system with B-lymphocyte cell membranes would promote antigen-
antibody interactions and minimize non-speciﬁ  c binding. To test this hypothesis, polystyrene 
96-well plate surfaces were modiﬁ  ed to possess similar topographies as those of B-lymphocyte 
cell membranes. This was accomplished by immobilizing Protein A conjugated gold particles 
and Protein A conjugated polystyrene particles ranging in sizes from 40 to 860 nm to the bottom 
of polystyrene wells. Atomic force microscopy results provided evidence of well-dispersed 
immunoassay–biosensor surfaces for all particles tested with high degrees of biologically 
inspired nanometer roughness. Testing the functionality of these immunosurfaces using 
antigenic ﬂ  uorescent microspheres showed that speciﬁ  c antigen capture increased with greater 
nanometer surface roughness while nonspeciﬁ  c antigen capture did not correlate with surface 
roughness. In this manner, results from this study suggest that large degrees of biologically 
inspired nanometer surface roughness not only increases the amount of immobilized antibodies 
onto the immunosurface membrane, but it also enhances the functionality of those antibodies 
for optimal antigen capture, criteria critical for improving immunoassay–biosensor sensitivity 
and speciﬁ  city.
Keywords: nanometer surface roughness, antibody-antigen interaction, B-lymphocyte, 
immunosurface, immunoassay, biosensor
Introduction
There are numerous immunoassay–biosensor applications necessitating highly sensitive 
pathogen detection. For example, aerosolized Bacillus anthracis spores are odorless, 
invisible to the naked eye, have the potential to travel many kilometers, and can survive 
for decades in ambient conditions. Extrapolation from primate studies have shown that 
between 1 and 3 of these spores may be sufﬁ  cient for an infection (Inglesby 2002). 
Unfortunately, current immunoassay–biosensor limitations lack the sensitivity and 
speciﬁ  city for proper B. anthracis spore detection (Service 2005). Hence, device 
improvement for the detection of such pathogens is of paramount importance.
Although there are a number of different designs to improve immunoassay–biosensor 
capabilities, one approach that has not received much attention to date is to mimic the 
nanostructure surface roughness of cells from our own immune system. Clearly, our 
own immune system has been optimized for antigen–antibody capture. For example, the 
avidity of the non-covalent interactions on a B-lymphocyte’s membrane suggests that International Journal of Nanomedicine 2006:1(4)  498
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many properties (such as ﬂ  exibility, charge, and roughness) 
may promote antigen capture. Several studies have observed 
and reported the nanometer membrane topography of a lym-
phoid cell using atomic force microscopy (Damjanovich et al 
1995; Cricenti et al 1999; Sakaue and Taniguchi 2001) or 
scanning electron microscopy (Setum et al 1993).
It should not be surprising that our own immune cells 
have highly nanostructured membranes due to the presence of 
membrane-linked proteins, phospholipid bilayers, and other 
bioactive molecules. Thus, it should also not be surprising that 
computational modeling has proposed that promoting surface 
roughness may be one way to enhance antigen capture on 
immunoassay–biosensor surfaces through enlarged antigen 
contact surface area (Zheng and Rundell 2003). In addition 
to increased surface area, nanoscale roughness on materials 
allows for unique energetics through greater portions of 
surface defects and altered electron delocalizations.
Because of this, nanometer surface roughness has been 
shown to inﬂ  uence the behavior of many cell types. For 
example, studies have demonstrated increased adhesion 
and growth of endothelial cells (Miller et al 2004), smooth 
muscle cells (Miller et al 2004), neurons (Ejiofor et al 2004), 
osteoblasts (Price et al 2003), and leukocytes (Eriksson et al 
2001) on nanometer compared with micron rough surfaces. 
Surface topography causes modulation of chemokines and 
cytokines in macrophages (Refai et al 2004), activation of 
platelets and monocytes (Hsu et al 2004), and changes in 
the locomotion of different T cell types (Mello et al 2003). 
Although showing promise for implant/tissue engineering 
applications, the use of nanometer surface roughness on 
immunoassay–biosensor membranes for enhancing antigen-
antibody capture remains largely uninvestigated.
For all of the above reasons, the objective of the 
present study was to investigate antigen capture on model 
immunoassay–biosensor surfaces of varying degrees of 
nanometer roughness. It is proposed that this biologically 
inspired nanometer surface roughness is one factor that 
naturally promotes antigen–antibody interactions which 
has yet to be explored in current immunoassay–biosensor 
designs.
Materials and methods
Immunosurface preparation
To determine the size of particles that should be used to 
model the surface roughness of B-lymphocytes, imaging 
software (ImageJ) was employed to evaluate the change in 
surface area (that is, the ratio of the outlined surface area 
of the cell membrane to that of a circle) of a B-lymphocyte 
from an image provided in the literature (Roitt et al 1993). 
The percentage change in surface area was calculated to be 
1.851431 ± 0.034405 (average ± SEM) This value was close 
to what could be obtained by using 860-nm diameter particles 
placed on ﬂ  at immunosurfaces; particles of two additional 
sizes (speciﬁ  cally, 40 and 460 nm) were added in this study 
for comparison purposes.
The model immunosurfaces were constructed in three 
layers through physisorption. IgG antibodies comprised the 
ﬁ  rst layer, the second layer consisted of either Protein A (PA) 
or PA conjugated particles, and the third layer contained the 
second antibody layer (Figure 1). The surface roughness was 
controlled by the size and surface density of the immobilized 
PA conjugated particles. All layers were constructed at 
room temperature (27°C). Throughout this immunosurface 
construction procedure, the samples were not allowed to dry 
to avoid non-uniformity (Hayes 1998).
 = Protein A
=Antibody
= Particles (40 nm, 460 nm, 860 nm) 
Experimental Conventional
= Polystyrene 96 Well Plate 
Figure 1 Model immunoassay surface construction. Experimental (left) and conventional 
(right) immunoassay surface construction scheme.
Construction of layer 1
In the present study, mouse IgG2aαDNP (anti-2,4-
dinitrophenol, kappa speciﬁ  c; Accurate Chemical) antibodies 
were used for the active surfaces and non-speciﬁ  c mouse 
IgG2a (kappa speciﬁ  c; Sigma) antibodies were used for 
the inactive surfaces. These antibodies were diluted in 1X 
phosphate-buffered saline (PBS) without ions (4.0 g NaCl, 0.1 
g KCl, 0.75 g Na2HPO4, and 0.1 g KH2PO4 added to 500 mL International Journal of Nanomedicine 2006:1(4)  499
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Milli-Q water, pH adjusted to 7.4) to a ﬁ  nal concentration of 
either 11.1, 6.7, or 3.3 μg/mL. 50 μL of this antibody solution 
was aliquoted to each sample well of a 96-well plate (poly-
styrene, ﬂ  at bottom without lid, high binding, non-sterile, 
EIA/RIA; Corning). The antibodies were adsorbed to the 
polystyrene surface for 1 hour. Samples were gently rinsed 
5 times with 200 μL of PBS in each well. The adsorption of 
the initial antibody layer results in a random orientation (Lu 
et al 1996), leaving some correctly oriented accessible Fc 
regions for the secondary attachment of PA.
Construction of layer 2
The second layer consisted of either PA (Sigma) or PA 
conjugated particles. The PA for the conventional surface 
was diluted in PBS to a ﬁ  nal concentration of 4 μg/mL. 
50 μL of the PA solution was adsorbed for 20 min and was 
gently washed 5 times with 200 μL of PBS in each well. 
The PA conjugated particles included 40-nm gold particles 
(OD = 10.1; Ted Pella, Inc), 460-nm yellow ﬂ  uorescent 
polystyrene particles (0.1% w/v; Spherotech, Inc), and 
860-nm polystyrene particles (1.0% w/v; Spherotech, Inc). 
PA conjugated particle concentrations were used at stock 
solution concentrations (8.7 × 1011 particles/mL, 18.0 × 109 
particles/mL, and 14.0 × 109 particles/mL for the 40, 460, and 
860 nm particles, respectively). To ensure that the only pro-
tein in the solution was PA conjugated to the particles, each 
solution was microcentrifuged (Model V, VWR) at 5585 × g 
at 4°C for 12 min, whereby the supernatant was removed and 
replaced with an equal volume of PBS. After replacement of 
the supernatant, the preparation was vortexed at 3200 rpm 
(speed setting 10) (Mini Vortexer, VWR) and was sonicated 
for 2 min (Aquasonic 75T, 90 W, VWR) to resuspend the 
particles in solution. This procedure was repeated twice. 
50 μL of the ﬁ  nal particle solution was adsorbed onto the 
ﬁ  rst layer of antibodies overnight. Alternatively, 50 μL of the 
ﬁ  nal particle solution was further diluted from this stock solu-
tion in PBS to the desired dilution factor (1:0, 1:10, 1:100, 
1:1000, and 1:10,000) which was then adsorbed overnight. 
The 96-well plate was covered with a lid as much as possible 
to avoid evaporation and contamination. After the particles 
adsorbed overnight, the samples were gently washed 5 times 
with 200 μL PBS in each well.
Construction of layer 3
The second antibody layer, either speciﬁ  c or non-speciﬁ  c, 
was adsorbed to form the third and ﬁ  nal layer of the model 
immunoassay surface. The procedure for the third layer was 
identical to that for the ﬁ  rst layer. The PA on the second layer 
served to correctly orient the antibodies through binding of 
PA to the Fc region of the antibody, allowing the Fab regions 
to be accessible to the antigen.
Immunosurface characterization
AFM measurements of surface roughness
Atomic force microscopy (AFM) was used to determine 
the topology and roughness of the various surfaces created 
in the present study. Speciﬁ  cally, samples were prepared 
for AFM by constructing only the ﬁ  rst two layers of the 
immunoassay membrane (as described above). Samples 
were mounted using double-stick tape (3M) onto 12-mm 
mica specimen discs (Ted Pella, Inc.) and were imaged 
using a Veeco Nanoscope IIIa MultiMode scanning probe 
microscopy (SPM) in TappingTM mode. Standard AFM tips 
and measuring conditions (thickness: 4 μm, width: 30 μm, 
length: 125 μm, force constant: 42 N/m, resonance frequency: 
320 kHz) were used in non-contact/Tapping™ mode with a 
reﬂ  exive coating (Paciﬁ  c Nanotechnology). Three AFM 5 × 
5 μm scans at 512 × 512 lines per image were taken for each 
sample, for 3 different samples of each surface type, at a rate 
of 1 Hz and a velocity of 10 μm/s. The average room tem-
perature during imaging was 24°C with an average humidity 
of 30%–40%. Three types of roughness measurements were 
calculated using Nanoscope IIIa 4.43r8 software in this study: 
root-mean-square roughness (RMS), average surface roughness 
(Ra), and the change in surface area (ΔSA) or Wenzel ratio. 
Three-dimensional topographic images were constructed using 
WSxM 4.0 Develop 4.4 software (Nanotec Electronica S.L.).
Hydrophilicity measurements
To determine hydrophilicity of the model immunoassay 
membranes, static contact angles were measured (Cam-Plus 
Contact Angle Reader, Tantec) in triplicate. In this manner, 
contact angles on each of the surfaces of interest to the present 
study (including the conventional surfaces) were measured 
immediately after adding 1 μL of Milli-q water using the 
Sessile Drop, Half-AngleTM Tangent line method (Tantec).
Protein A quantiﬁ  cation
An estimate of the PA surface density was obtained for 
the different immunosurface constructs by multiplying 
the amount of PA determined per particle times the surface 
density of the particles as determined from the above 
mentioned 5 × 5 μm AFM scans. A well-established BCA™ 
(Pierce) commercially available technique was used to 
determine the amount of PA per particle from stock solutions 
of a known concentration of particles.International Journal of Nanomedicine 2006:1(4)  500
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Functionality of immunosurfaces: antigen binding
Undoubtedly, the most important characteristic of an 
immunoassay–sensor is its ability to bind antigen. To test 
this, the functionality of the immunosurface was assessed by 
considering both speciﬁ  c and non-speciﬁ  c antigen capture. 
Antigens were modeled as microspheres (MSs) in the present 
study. Speciﬁ  c antigen interactions were quantiﬁ  ed by the 
number of bound active MSs (DNP-BSA) to the immuno-
surfaces constructed with speciﬁ  c antibodies (IgG). Three 
types of non-speciﬁ  c interactions were investigated: (1) 
non-speciﬁ  c antibody (IgG (NS)) surfaces exposed to active 
and (2) control MSs, and (3) speciﬁ  c antibody (IgG) surfaces 
exposed to control MSs. Only active MS non-speciﬁ  c binding 
was reported due to space limitations as the other two types 
of non-speciﬁ  c binding were always less than this value. The 
various surface types were constructed as described above 
and the antigens were constructed and exposed to the immu-
nosurfaces as described in the sections that follow.
Antigen preparation
The antigen used for testing the functionality of the 
immunosurfaces for both speciﬁ  c and non-speciﬁ  c binding 
was an antigenic complex of DNP conjugated to bovine 
serum albumin (BSA) (Molecular Probes with a valency of 
22.8) adsorbed onto carboxylate-modiﬁ  ed, 1 μm polystyrene 
Nile red ﬂ  uorescent MSs (Excitation: 535 nm, Emission: 
575 nm; FluoSpheres, Molecular Probes); this created active 
MSs for testing speciﬁ  c binding to the various immunosur-
faces. For this purpose, lyophilized DNP-BSA powder was 
reconstituted in PBS to form a DNP-BSA solution concentra-
tion of 1.25 mg/mL, where the ﬂ  uorescent MSs (2.0% solids 
stock) were added at a ratio of 1:20, vortexed at 3200 rpm, 
and allowed to sit in the dark at 4°C for 2 days to allow for 
the adsorption of the antigen (DNP-BSA) onto the ﬂ  uorescent 
MSs. The MS/DNP-BSA solution was then microcentrifuged 
at 5585 × g at 4°C for 20 min, whereby the derivatized MS 
pellet was washed and resuspended by vortexing with PBS. 
The resuspended MS/DNP-BSA solution was allowed to sit 
and cure for at least 3 days at 4°C in the dark to stabilize the 
MS/DNP-BSA interaction. Control microspheres for testing 
non-speciﬁ  c binding were constructed from BSA adsorbed to 
the MSs, prepared using the procedure mentioned above with 
1.25 mg/mL BSA replacing the DNP-BSA solution.
Quantifying antigen capture on immunosurfaces
Following the construction of the various immunosurfaces, 
50 μL (2.4 ×106 MS) of active (DNP-BSA) or control (BSA) 
MSs were exposed to the various immunosurfaces in the 96 
well plate for 10 min. 50 μL of each solution of active and 
control MSs were produced from an overall 1.15 mL solution 
that consisted of 30 μL of the respective stock solution in 
1 mL of PBS and 120 μL of BlockAid™ (Molecular Probes). 
BlockAid™ is a proprietary protein solution which limits 
non-speciﬁ  c binding when using Molecular Probes MSs 
(Molecular Probes Product Information, 2001). After the 
MSs were allowed to interact with the immunosurfaces for 
10 min, samples were gently rinsed 5 times with 200 μL of 
PBS in each well. One image per well (within the center) 
was collected using an inverted ﬂ  uorescent microscope 
(Leica DM IRB) equipped with Texas red isothiocyanate 
(TRITC)-compatible ﬁ  lters (BP 515–560, LP 590, Leica) 
and a capacitive coupled display (CCD) camera at 10x 
magniﬁ  cation. Bound MSs were counted using ImagePro 
Plus software.
Statistical analyses
Analysis of variance (ANOVA) with a variance stabilization 
procedure was performed to determine differences between 
the surfaces of interest to the present study. Experimental data 
(reported as average ± SEM)) were analyzed using Tukey’s 
procedure (the T method). A two-sample t-test was used in 
a few cases in which unequal sample sizes existed.
Results and discussion
Immunosurface characterization: 
roughness
As expected, large differences in surface roughness were 
observed through the use of the various particle sizes in 
the present study (Figure 2 and Table 1). Most importantly, 
results demonstrated increased surface roughness through the 
addition of particles to the polystyrene wells. Speciﬁ  cally, 
the highest degree of roughness was observed with the use 
of 860-nm followed by 460-nm followed by 40-nm diameter 
particles; all had greater surface roughness than polystyrene 
alone. As a reminder, the type of surface roughness that best 
modeled that of a B-lymphocyte from an image provided in 
the literature (Roitt et al 1993) was through the use of 860-nm 
diameter particles.
Immunosurface characterization: 
antigen binding
Results of this study provided evidence that speciﬁ  c antigen 
capture increased as the surface roughness increased, while 
non-speciﬁ  c antigen capture was independent of surface 
roughness (Figure 3). The change in surface roughness data International Journal of Nanomedicine 2006:1(4)  501
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A. Polystyrene alone  B. 40 nm particles
C. 460 nm particles       D. 860 nm particles
Figure 2 3D AFM images of immunoassay surfaces. AFM 3D surface images with physisorbed antibody concentrations of 11.1 μg/mL obtained using tapping mode in air on 
(A) a conventional 96-well polystyrene plate alone, (B) 40-nm gold nanoparticles conjugated with Protein A attached to a 96-well plate, (C) 460-nm polystyrene particles 
conjugated with Protein A attached to a 96-well plate, and (D) 860-nm polystyrene particles conjugated with Protein A attached to a 96-well plate.
Table 1 Surface roughness summary
Particle Size Surface  Surface roughness variations (data = mean ±SEM)
roughness 
measurement
Control
(conventional)
Particle serial dilutions
1:0 1:10 1:100 1:1000 1:10,000
40 nm RMS (nm) 4.073
±0.259
23.357
±3.102
11.933
±1.372
4.478
±0.211
2.665
±0.129
3.167
±0.356
Ra (nm) 2.949
±0.199
18.714
±2.623
7.319
±1.045
2.775
±0.433
1.898
±0.082
2.173
±0.116
Δ SA 1.011
±0.004
1.239
±0.012
1.075
±0.007
1.023
±0.003
1.016
±0.002
1.013
±0.002
460 nm RMS (nm) 4.073
±0.259
92.129
±3.157
98.384
±5.251
29.958
±5.539
4.238
±1.110
3.425
±0.667
Ra (nm) 2.949
±0.199
73.524
±2.701
69.264
±6.456
10.666
±1.824
2.359
±0.227
2.127
±0.124
Δ SA 1.011
±0.004
1.302
±0.016
1.147
±0.014
1.023
±0.007
1.000
±0.001
0.999
±0.001
860 nm RMS (nm) 4.073
±0.259
203.39
±7.564
237.062
±4.897
103.267
±28.351
29.422
±17.646
2.549
±0.213
Ra (nm) 2.949
±0.199
159.32
±8.173
195.777
±4.667
64.364
±20.848
20.922
±14.703
1.968
±0.201
Δ SA 1.011
±0.004
1.401
±0.013
1.589
±0.025
1.127
±0.037
1.043
±0.018
1.002
±0.002
Abbreviations: RMS, root-mean-square roughness; Ra, average surface roughness; ΔSA, change in surface roughness or Wentzel ratio; Control (conventional), no particles used.International Journal of Nanomedicine 2006:1(4)  502
Tuttle et al
within each surface type reﬂ  ects the serial dilutions of the 
particles (1:0, 1:10, 1:100, 1:1000, and 1:10000). These data 
showed that even though surface roughness may be a factor, 
there are likely other factors involved in mediating antigen 
capture, such as surface chemistry changes or alterations in 
PA surface density. This is likely since at the 100-nm surface 
roughness regime there is a difference in speciﬁ  c and non-
speciﬁ  c antigen capture between surface types. This can be 
further conﬁ  rmed in Figure 4 where at the 100-nm surface 
roughness regime the surface types have different energetics, 
as determined through contact angle measurements. This may 
be due to a change in surface chemistry from the different types 
of polystyrene particles used and/or the different amounts of 
PA conjugated on those particles. Moreover, in Figure 4 it can 
be seen that within each immobilized particle type, the surface 
energetics change as the surface roughness changes.
It is important to note that Figure 4 complements Figure 3 
since collectively they show that when either surface rough-
ness or surface energetics (that is, contact angles) were 
held constant, there was still a change in speciﬁ  c and non-
speciﬁ  c antigen capture. That is, speciﬁ  c and non-speciﬁ  c 
antigen capture is most likely due to a combination of a 
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change in surface chemistry and surface roughness, with 
surface roughness playing a larger role in speciﬁ  c antigen 
capture than non-speciﬁ  c antigen capture.
To investigate further what properties may have changed 
when using the more rough surfaces (that is, those with 860-nm 
particles), surface chemistry differences possibly due to various 
amounts of PA were evaluated. Results provided evidence that 
the density of PA was not correlated with surface roughness 
and that speciﬁ  c and non-speciﬁ  c antigen capture did not 
depend solely on the density of PA on the surface (Figure 5). 
Speciﬁ  cally, the 460- and 860-nm particle surfaces had similar 
amounts of PA yet the 860-nm particle surface enhanced 
antigen capture. As seen in Figures 3 and 4, this again suggests 
that the surface roughness created in this study through the 
use of various nanometer particle sizes did not cause different 
surface energetics that manipulated protein density.
When analyzing different physisorbed antibody concen-
trations, the disproportionate increases in speciﬁ  c antigen 
capture on the 860-nm particle surface may be explained 
due to a greater amount of antibody immobilized and/or 
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Figure 5 (Left) PA surface density did not depend on surface roughness; (Right) speciﬁ  c antigen capture did not depend on pa surface density. (Left) The 40-nm particle 
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Statistics:  All surfaces statistically signiﬁ  cant different to each other with p<0.01 with respect to surface roughness (RMS) and PA density.
(Right) Circle highlights the change in speciﬁ  c antigen capture without a change in PA density. Data = mean ± SEM.
Statistics: 860-nm 1:0 active MS surface is statistically signiﬁ  cantly different from all 860-nm surfaces except 1:10 with p<0.01 (*). 860-nm 1:10 active MS surface compared 
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greater surface roughness and physisorbed antibody concentrations. Speciﬁ  c antigen capture at antibody physisorbed concentrations of 11.1 μg/mL increased by approxi-
mately 540% when the surface roughness (RMS) increased by approximately 1900% (that is, going from conventional or polystyrene alone surfaces to those with 860 nm 
particles). Data = mean +/− SEM.
Statistics: Statistical grouping by 11.1 μg/mL, 6.7 μg/mL, 3.3 μg/mL physisorbed Abs, and all data. 11.1 μg/mL active MSs 860-nm surface is statistically signiﬁ  cantly different 
frp, all surfaces with p<0.01 (*). 6.7 μg/mL active MSs 860-nm surface compared with all surfaces with p<0.01 (**). 3.3 μg/mL Active MSs 860-nm surface compared with all 
surfaces with p<0.01 (***). 3.3 μg/ml active MSs 460-nm surface compared with 40-nm surface with p<0.1 (****). Within all data 11 μg/ml 860-nm compared with all sur-
faces with p<0.01 expect for with the 6.7 μg/mL 860-nm with P < 0.05 (*****). N=20 for 11.1 μg/mL, N=5 for 6.7 μg/ml and 3.3 μg/mL. Statistical grouping by particle type. 
11.1 860-nm compared with 6.7 and 3.3 860-nm with p<0.01 (#), 6.7 860-nm compared to 3.3 860-nm with p<0.05 (##). 11.1 460-nm compared with 6.7 and 3.3 460-nm 
with p<0.01 (###), 6.7 460-nm compared with 3.3 460-nm with p<0.01 (####). N=20 for 11.1 μg/ml, N=5 for 6.7 μg/ml and 3.3 μg/ml.International Journal of Nanomedicine 2006:1(4)  504
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a greater functionality of those immobilized antibodies 
(Figure 6). Comparison of Figures 3, 4, and 5 highlights the 
possibility that it may not just be the amount of IgG adsorbed 
but the functionality of those adsorbed antibodies, since the 
most speciﬁ  c binding was not found on the surface with the 
most PA.
Reasons for altered antigen binding
When surface roughness and surface chemistry are both 
changed, as was done here, it is difﬁ  cult to determine to what 
extent each variable is contributing to speciﬁ  c and nonspe-
ciﬁ  c antigen capture. However, the results of the present 
study demonstrated that surface roughness is an important 
parameter for increasing antigen capture. Moreover, the larg-
est speciﬁ  c antigen capture was seen when 860-nm particles 
were used on the immunoassay surfaces, which corresponded 
to the aforementioned estimate of the surface roughness of 
a B-lymphocyte membrane.
In this manner, one explanation of why antibody 
functionality may be enhanced when immobilized on 
increasingly roughened immunosurfaces may lie with the 
probabilistic geometrical nature of a roughened surface. 
That is, various non-covalent forces govern every antigen–
antibody binding event. These different forces vary in 
strength depending on the distance between an antigen and 
an antibody. It can then be rationalized that the surface 
area of an immunoassay–sensor is mirrored in solution due 
to these varying forces. Thus, a more rough immunoassay 
surface may result in a more rough mirrored antigen contact 
area created by the non-covalent forces within the solution. 
Probabilistically, antigens in solution will be more likely to 
interact with these non-covalent forces to result in speciﬁ  c 
antigen capture. In other words, the functionality of the 
individual antibodies may not be intrinsically enhanced, but 
the collective whole of the antibodies on the immunosurface 
may be enhanced.
Conclusions
In conclusion, this study provided evidence that nanometer 
surface roughness may be a critical design parameter for 
future immunoassays–sensors since the sensitivity of an 
antibody–antigen capture may be enhanced without an 
increase in non-speciﬁ  c binding. An increase in nanometer 
surface roughness was observed in this study through the 
use of larger immobilized particles. It then followed that a 
decrease in surface roughness was created through serial 
dilutions of those immobilized particles. Greater speciﬁ  c 
antigen capture correlated with increased surface roughness 
and physisorbed antibody concentrations, while nonspeciﬁ  c 
antigen capture was independent of surface roughness. 
Surface energetic experiments involving contact angles 
suggested that there might be a change in surface chemistry 
between the different immunoassay surface types. However, 
even amidst a possible surface chemistry change, results of 
this study implied that nanometer surface roughness was 
the dominating factor that contributed to greater speciﬁ  c 
antigen capture. Such knowledge of the use of nanostruc-
tured surface roughness should be used to design better 
immunoassays/biosensors.
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